文献速递类风湿关节炎

类风湿关节炎患者多病共存与合并症随年龄和性别的差异

Disparities in multimorbidity and comorbidities in rheumatoid arthritis by sex across the lifespan.
PubMed 文献 · Rheumatology (Oxford) · 2024-01-01

该横断面分析基于2010—2019年OptumLabs®数据仓库的国家行政理赔数据,纳入154 391例RA患者和154 391例按年龄、性别、种族、普查区域、索引年份和基线保险覆盖时长匹配的非RA对照。RA女性较RA男性多病共存(≥2种或≥5种合并症)的百分比增幅大于非RA女性较非RA男性的增幅,且RA加剧了性别差异(P < 0.05),在18—50岁人群中更明显。

要点

  • 18—50岁RA女性较RA男性多病共存(≥2种)百分比增加7.5个百分点,≥5种增加4.4个百分点。
  • 51岁及以上RA女性较RA男性多病共存(≥2种)增加2.1个百分点,≥5种增加2.5个百分点。
  • RA女性心理、神经和一般肌肉骨骼类合并症更多,男性心血管相关合并症更多。

核心结论

  • 多病共存对RA女性的影响不成比例地更大。
  • 风湿病研究、临床和政策议程应承认并支持整个生命周期中因性别和社会性别不同而异的照护需求。

研究设计与样本

  • 横断面分析,使用2010—2019年OptumLabs®数据仓库的国家行政理赔数据。
  • 纳入154 391例RA患者和154 391例非RA对照,按年龄、性别、种族、普查区域、索引年份和基线保险覆盖时长匹配。
  • RA通过经验证的算法确定,多病共存定义为来自44种慢性病经验证集合中的≥2种(MM2+)或≥5种(MM5+)合并症。
  • 使用逻辑回归评估特征与多病共存之间的关联。

主要发现

  • 18—50岁人群:RA女性较RA男性MM2+增加7.5个百分点、MM5+增加4.4个百分点;非RA女性较非RA男性MM2+增加3.2个百分点、MM5+增加0.9个百分点。
  • 51岁及以上人群:RA女性较RA男性MM2+增加2.1个百分点、MM5+增加2.5个百分点;非RA女性较非RA男性MM2+增加1.2个百分点、MM5+增加0.3个百分点。
  • 交互作用显示,RA(较非RA)加剧了女性和男性之间多病共存的差异(P < 0.05),在18—50岁人群中效应更明显。
  • 男性有更多心血管相关疾病,而RA女性有更多心理、神经和一般肌肉骨骼疾病。
  • 其他合并症因性别和年龄而异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Multimorbidity is burdensome for people with RA. We investigated differences in multimorbidity and comorbidities by sex and age in the RA population. METHODS: This cross-sectional analysis used national administrative claims (OptumLabs® Data Warehouse) from people with RA and non-RA comparators (matched on age, sex, race, census region, index year and length of baseline insurance coverage) from 2010-2019. RA was determined using a validated algorithm. Multimorbidity was defined as ≥2 (MM2+) or ≥5 (MM5+) comorbidities from a validated set of 44 chronic conditions. We used logistic regression to assess associations between characteristics and multimorbidity. RESULTS: The sample included 154 391 RA patients and 154 391 non-RA comparators. For people aged 18-50 years, RA women (vs RA men) had 7.5 and 4.4 (vs 3.2 and 0.9 in non-RA women vs non-RA men) percentage point increases for MM2+ and MM5+, respectively. For people aged 51+ years, RA women (vs RA men) had 2.1 and 2.5 (vs 1.2 and 0.3 in non-RA women vs non-RA men) percentage point increases for MM2+ and MM5+, respectively. Interactions revealed that differences in multimorbidity between women and men were exacerbated by RA (vs non-RA) (P < 0.05), with more pronounced effects in people aged 18-50. Men had more cardiovascular-related conditions, whereas RA women had more psychological, neurological and general musculoskeletal conditions. Other comorbidities varied by sex and age. CONCLUSION: Multimorbidity disproportionately impacts women with RA. Research, clinical and policy agendas for rheumatic diseases should acknowledge and support the variation in care needs by sex and gender across the lifespan.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Stevens MA, Dykhoff HJ, Kronzer VL, et al. Disparities in multimorbidity and comorbidities in rheumatoid arthritis by sex across the lifespan. Rheumatology (Oxford). 2024. PMID: 37651451. doi:10.1093/rheumatology/kead454

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。